Avella Recalls Bevacizumab Syringes Due to Sterility Assurance Concerns
Avella of Deer Valley is recalling 911 pre-filled Bevacizumab syringes due to a lack of assurance of sterility. The product was distributed throughout the United States.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (sterility issue) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.
Plain-English summary
Avella of Deer Valley, Inc. is recalling 911 pre-filled syringes of Bevacizumab 2.5 mg/0.1 mL (NDC 42852-001-24). The specific lot affected is # 138-20182408@58, with a beyond-use date of 12/22/2018. The product was repackaged by Avella Specialty Pharmacy in Phoenix, Arizona, and distributed throughout the United States.
The recall was initiated due to a lack of assurance of sterility. The source text does not report any specific illnesses, injuries, or fatalities associated with the use of this product.
Consumers and healthcare providers should stop using the affected syringes and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella Specialty Pharmacy, 24416 N 19th Avenue, Pheonix, AZ 85085. NDC 42852-001-24
- Manufacturer
- Avella of Deer Valley, Inc. Store 38
- Category
- Drug — Biologic
- Hazard
- Affected units
- 911
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # 138-20182408@58 BUD 12/22/2018
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Avella of Deer Valley, Inc. Store 38
See all →- SevereAvella Recalls Povidone Iodine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2019-10-30
- SevereAvella Recalls Bevacizumab Prefilled Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-06-05
- ModerateAvella Recalls Magnesium Sulfate Bags Due to Incorrect Barcode Expiration Dates
FDA (Drugs) · 2019-02-20
- ModerateAvella Recalls Labetalol Syringes Due to Incorrect Barcode Expiration Dates
FDA (Drugs) · 2019-02-20
- ModerateAvella recalls magnesium sulfate bags with incorrect barcode expiration dates
FDA (Drugs) · 2019-02-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29